Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock, $0.00001 par value
-
Shares outstanding
-
60,530,801
-
Total 13F shares
-
40,108,316
-
Share change
-
+40,108,210
-
Total reported value
-
$848,591,959
-
Price per share
-
$21.30
-
Number of holders
-
72
-
Value change
-
+$848,589,611
-
Number of buys
-
71
Institutional Holders of Apogee Therapeutics, Inc. - Common Stock, $0.00001 par value (APGE) as of Q3 2023
As of 30 Sep 2023,
Apogee Therapeutics, Inc. - Common Stock, $0.00001 par value (APGE) was held by
72 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
40,108,316 shares.
The largest 10 holders included
VR Adviser, LLC, FMR LLC, Fairmount Funds Management LLC, Deep Track Capital, LP, RTW INVESTMENTS, LP, RA CAPITAL MANAGEMENT, L.P., PERCEPTIVE ADVISORS LLC, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, and ORBIMED ADVISORS LLC.
This page lists
72
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.